In contrast, the dysfunction regulation of adiponectin and its receptors has been observed in the development of various diseases, including obesity, insulin resistance, type 1 and type 2 diabetes, and chronic kidney disease [29]. This evidence concerns the gene ADIPOQ and chronic kidney disease.